EQUITY RESEARCH MEMO
NeuraMedica
Generated 5/10/2026
Executive Summary
Conviction (model self-assessment)45/100
NeuraMedica Inc. is a privately-held medical device company based in San Diego, developing innovative neurosurgical solutions. Its flagship product, DuraFuse, is a bioabsorbable, non-penetrating clip system designed for rapid and secure closure of the spinal dura mater, aiming to replace traditional suturing and sealants. Founded in 2018 on technology from Oregon Health and Science University, the company is distinguished as woman-owned and Native-owned. While still in early stages, NeuraMedica addresses a significant unmet need in neurosurgery by potentially reducing operative time and complications associated with CSF leaks. The company's progress will depend on clinical validation and regulatory clearance.
Upcoming Catalysts (preview)
- TBDFirst-in-human clinical trial initiation50% success
- TBDFDA 510(k) submission or breakthrough device designation40% success
- TBDStrategic partnership or funding round60% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)